Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder
The Effects of Mindfulness on Disrupted Sleep in Bipolar Disorder
1 other identifier
interventional
48
1 country
1
Brief Summary
The investigators propose to investigate the efficacy of a brief (4-session) Body Scan (BS) meditation intervention for individuals with bipolar I disorder with insomnia (i.e. difficulties falling or staying asleep). The investigators will compare the Body Scan intervention with a 4-session brief supportive psychotherapy (SP) intervention. The investigators hypothesize that the Body Scan will improve objective sleep quantity and quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2013
CompletedFirst Posted
Study publicly available on registry
January 9, 2013
CompletedStudy Start
First participant enrolled
February 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedJune 24, 2016
June 1, 2016
3 years
January 7, 2013
June 22, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Sleep Time (TST)
8 weeks
Secondary Outcomes (2)
Young Mania Rating Scale (YMRS)
20 weeks
Hamilton Depression Rating Inventory (HAM-D 17).
20 weeks
Study Arms (2)
Brief Supportive Psychotherapy (SP)
ACTIVE COMPARATOR30 people will be randomized to receive Brief Supportive Psychotherapy.
Body Scan (BS) Meditation Intervention
EXPERIMENTAL30 people will be randomized receive the Body Scan Meditation Intervention.
Interventions
This intervention consists of 4 individual 60-minute sessions (week 1, 2, 4, and 6) in which participants learn the body scan meditation exercise and practice it at home, daily, lying in bed at their usual bedtime after going to bed (and when waking up at night, unable to go back to sleep). The Body-Scan meditation consists of a 30-minute exercise during which participants are guided to focus their attention on certain parts of their body (e.g. toes, feet). The core skill involves gradually adopting an observant, non-judgmental, and accepting stance towards bodily sensations, including feelings and thoughts.
SP is a common form of non-specific psychotherapy available to patients with bipolar disorder in the community. It focuses on addressing a patient's current concerns, supporting a patient's adaptive coping skills, improving self-esteem, and expressing feelings and the therapeutic alliance. Using a conversational style, SP involves conveying empathy, validation, comforting and supporting patients in coping with distress about current life issues as well as providing encouragement and praise, clarification and opportunity to vent. SP will match BS in length, number of sessions and delivery schedule (four, 60-minute sessions, week 1, 2, 4, 6).
Eligibility Criteria
You may qualify if:
- Men and women age 18-65
- DSM-IV diagnosis of bipolar I or II disorder
- HAM-D-17 score \< 17 (i.e. low or no depressive symptoms)
- YMRS score \< 8 (i.e. no or low manic symptoms)
- Optimized, stable maintenance pharmacotherapy at maximum tolerated dosages in accordance with the revised Texas Implementation of Medication Algorithm
- DSM-IV insomnia A and B criteria are met (i.e. difficulty initiating or maintaining sleep, for at least 1 month) as operationally defined by:
- Insomnia Severity Index score of \> 15 (moderate clinical insomnia)
- M1 derived average actigraphic total sleep time \< 6 hours, and \< 40% average total sleep time in high frequency coupling, as measured with the M1 device over 5 days pre-randomization, corresponding to \< 1SD below the mean of the M1 normative comparison sample of healthy control participants.
You may not qualify if:
- DSM-IV bipolar I disorder subtype rapid cycling
- DSM-IV manic or mixed episode in the past 2 months
- DSM-IV major depressive episode in the past 2 months
- Psychotropic medication not in accordance with the revised Texas Implementation of Medication Algorithm
- Pregnancy
- Medical illness or non-psychiatric medical treatment that is the likely cause of the sleep disturbance or interferes with study participation
- Neurologic disorder, previous ECT, or history of head trauma (i.e. known structural brain lesion)
- Current or past history of selected DSM-IV Axis I disorders other than bipolar disorder including: organic mental disorder, substance abuse within the past 12 months and/or history of substance abuse for \> 1 year; past or current substance dependence (including alcohol), schizophrenia, delusional disorder, psychotic disorders not otherwise specified
- Axis I disorder that needs to be the primary focus of treatment (e.g. current DSM-IV anxiety disorder that disrupts sleep)
- Sleep apnea, restless leg syndrome, or narcolepsy
- Concurrent psychotherapy to BS or SP.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thilo Deckersbach, Ph.D.
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Psychology
Study Record Dates
First Submitted
January 7, 2013
First Posted
January 9, 2013
Study Start
February 1, 2013
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
June 24, 2016
Record last verified: 2016-06